In addition, in the second half of 2025, Verve remains on track to report the final data for the dose escalation portion of the Heart-2 clinical trial, deliver the opt-in package for the PCSK9 program ...

Whatever the reasoning behind the telework shift, former federal officials say it’s a sign that recently confirmed FDA ...

Last year, the Pharmacy and Poisons Board removed more than 30 drugs from the market because they were either substandard or ...